Norton Cancer Institute patient receives first-in-world clinical trial medicine dos | Louisville ...

John T. Hamm, M.D., is the first to administer a Phase 1 clinical trial medication for solid tumors, sponsored by OncoC4 Inc., at Norton Cancer Institute. The trial aims to reduce tumor size and slow spread in advanced/metastatic solid tumors.